Nevada will receive a portion of a multi-state cash settlement involving drug maker GlaxoSmithKline.
In an announcement by the office of Attorney General Catherine Cortez Masto, the Silver State was one of 38 states that reached a settlement in a case involving diabetes drug Avandia.
Each state accused the drug maker in unfair and deceptive practices by misrepresenting the drug's cardiovascular risks and safety profile, according to Masto's office.
Nevada will receive about $1.5 million of the $90 million settlement.
GlaxoSmithKlein has agreed to reform how it markets and promotes diabetes drugs as part of the settlement, Masto's office said.
"These enforcement provisions are important to protect Nevadans and others across the country," said Masto. "I am pleased to join this multistate agreement to ensure that Nevadans are not misled by this company's deceptive marketing practices."
Stay tuned to FOX5 for the latest on this developing story.
Copyright 2012 KVVU (KVVU Broadcasting Corporation). All rights reserved.
Wednesday, August 27 2014 7:48 PM EDT2014-08-27 23:48:57 GMT
Omaha police say officers' gunfire killed 'Cops' television show crew member and a robbery suspect at a fast-food restaurant.More >
Police officers who opened fire while disrupting a robbery at a fast-food restaurant in Omaha killed a crew member with the TV show "Cops" as well as the suspect, who was armed with a pellet gun that they thought was a...More >